Intelligent Pills Market-Global Industry Analysis and Forecast (2022-2029)


Global Intelligent Pills Market is expected to grow at a CAGR of 10.53% during the forecast period. Global Intelligent Pills Market is expected to reach US$ 15.46 Bn. by 2029.

Global Intelligent Pills Market Definition:

A smart pill is an ingestible medical device mainly available in a capsule sized vitamin pill and which in combination with a small electronic embedded product or appliances and drugs in it, such as patches, trackers, camera or sensors, sends wireless information about patients health parameters that help in monitoring and better diagnosis. Which, once swallowed, gets activated and offer non-invasive examination. Besides, smart pills have revolutionized the gastrointestinal diagnosis procedure and are likely to replace conventional diagnostic technique to give a potent alternative approach such as gastrointestinal endoscopy

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Global Intelligent Pills Market

To know about the Research Methodology :- Request Free Sample Report

Global Intelligent Pills Market Dynamics:

The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors involve the drivers, restraints, opportunities and challenges for the key companies and stakeholders in the industry.

The increasing need for minimally invasive devices, accurate therapeutic treatment strategies with increasing medication adherence, led to increasing demands for non-invasive diagnostic smart pills procedures, because of the fewer side-effects, ease of operation, better diagnostics of life-threatening medical conditions and various investment by many manufactures in R&D promotes improved drug portfolio. According to the report analysis, increasing medication and preference over conventional diagnostic devices for convenient and the small bowel diseases diagnosis will contribute to increasing demand for non-invasive drug therapy and smart pills which in turn will lead to market growth.

However, certain barriers such as high cost related with the ingestible sensors and stringent regulations concerning the increased use of technical devices, lack of knowledge and fear among patients about swallowing a microchip are few many factors estimated to restrain the market growth.

Global Intelligent Pills Market Opportunities:

Moreover, the increase in technological advances relating to smart pills such as micro-cameras, availability of microprocessors, bioelectronics, miniaturization, and others are expected to offer beneficial opportunities in future.
Key Developments in the Market:
In Jan 2021, PwC Australia at present aligned with TruTag and Colorcon to improve an innovative solution that inspires supply chain transparency in the pharmaceutical sector.

Global Intelligent Pills Market Market Segment Analysis:

The report covers competitive analysis of the Intelligent Pills Market in each of the geographical segments thereby providing insight into a market share at the macro as well as micro levels.

On the basis of application, capsule endoscopy segment is estimated to have more than half of total market share because of the innovation in technology advancement and growing acceptance of smart pills for GI disease diagnosis and treatment, such as small bowel disease diagnosis in intestine and colon cancer in which would register the highest CAGR of 13.6% because of the esophageal diseases and others research analysis and increasing occurrences of colon cancer.

In terms of End- User, hospital pharmacy is accounted to have more than half of total market share and is expected to continue its dominance over the forecast with the highest CAGR of 12.6% from 2021 to 2029, because of the increasing acceptance of capsule endoscopes in GI tract disorders diagnosis rate with increasing hospitalization using less time-consuming protocols, improved efficiencies with cost-efficient procedure and patient compliance.

Global Intelligent Pills Market Regional Insights

North America’s Intelligent Pills Market was valued at US$ 995 Mn in 2021 and is expected to reach a value of US$ 2215 Mn by 2029, with a CAGR of 17.2%. North America is the largest market and accounted to dominate nearly half of the market with 57.1% share of which U.S, Canada contributes for major market because of the rapid acceptance of new endoscopic technologies, approvals by FDA, technological advancements, positive reimbursement scenario and increasing funding on investments by government and other companies in R&D for clinical trial as to potential growth also increasing cases of collateral cancer and for smart pills are many factors that will propel the market growth.

However, Asia-Pacific excluding japan registers the highest CAGR of 14% because of the high incidences to GI disorders and large investment for R&D by major agencies and government support and health insurance All these factors are responsible deliver the growth.

Competitive Analysis Global Intelligent Pills Market:

These market players in the Intelligent Pills Market have implemented various strategies such as partnerships, joint ventures, collaborations, expansions, new product launches and other crucial aspects to lessen the competition in the competitive landscape

Technavio is a leading global research company of North America in the U.S with US$ 212.97 million in smart pills during 2021-2029. Followed by Major manufacturers covered in the smart pills market are Chongqing Jinshan Science & Technology (Group) Co. Ltd., CapsoVision Inc., Intromedic Co. Ltd., Medtronic Plc, Olympus Corp., and Otsuka Holdings Co. Ltd.

Global Intelligent Pills Market Scope: Inquire before buying






Global Intelligent Pills Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 6.94 Bn.




Forecast Period 2022 to 2029 CAGR:
10.53%
Market Size in 2029:
US $ 15.46 Bn.




 Segments Covered:
by Application
• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring




by Target Area
• Esophagus
• Stomach
• Small Intestine
• Large Intestine




by Type
• Occult GI Bleeding
• Chron’s disease
• Small bowel tumors
• Celiac disease
• Inherited polyposis syndromes
• Neurological disorder
• Other disease indications




by End-User
• Hospital Pharmacy
• Clinics
• Research Institutes
• Home Healthcare






Global Intelligent Pills Market, by Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Global Intelligent Pills Market, key Players

• Medtronic, Inc.
• Proteus Digital Health
• CapsoVision, Inc.
• Olympus Corporation
• Medisafe
• Medimetrics & Bio-Images Research
• Given Imaging, Inc
• Philips Healthcare.
• Technavio
• Boston Scientific Corporation
• GE Healthcare
• Keratin Biosciences, Inc.
• Lloyds Pharmacy
• Ostuka Holdings Co., Ltd.
• 2Morrow Inc.
• GINGER.IO,
• PureTech Health,
• Livongo Health,
• AliveCor, Inc.,
• WellDoc, Inc.,
• Volutis,
• Omada Health, Inc

Frequently Asked Questions:

1. Which region has the largest share in Global Intelligent Pills Market?
Ans: North America region held the highest share in 2021.

2. What is the growth rate of Global Intelligent Pills Market?
Ans: The Global Intelligent Pills Market is growing at a CAGR of 10.53% during forecasting period 2022-2029.

3. What is scope of the Global Intelligent Pills market report?
Ans: Global Intelligent Pills Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Intelligent Pills market?
Ans: The important key players in the Global Intelligent Pills Market are – Medtronic, Inc., Proteus Digital Health, CapsoVision, Inc., Olympus Corporation, Medisafe, Medimetrics & Bio-Images Research, Given Imaging, Inc, Philips Healthcare., Technavio, Boston Scientific Corporation, GE Healthcare, Keratin Biosciences, Inc., Lloyds Pharmacy, Ostuka Holdings Co., Ltd., 2Morrow Inc., GINGER.IO,, PureTech Health,, Livongo Health,, AliveCor, Inc.,, WellDoc, Inc.,, Volutis,, Omada Health, Inc

5. What is the study period of this market?
Ans: The Global Intelligent Pills Market is studied from 2021 to 2029. 




Global Intelligent Pills Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Intelligent Pills Market Size, by Market Value (US$ Bn) & Volume (Unit)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators
6. Global Intelligent Pills Market Analysis and Forecast
6.1. Global Intelligent Pills Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Intelligent Pills Market Analysis and Forecast, By Application
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Intelligent Pills Market Value Share Analysis, By Application
7.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By Application
7.5. Global Intelligent Pills Market Analysis, By Application
7.6. Global Intelligent Pills Market Attractiveness Analysis, By Application

8. Global Intelligent Pills Market Analysis and Forecast, By Target Area
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Intelligent Pills Market Value Share Analysis, By Target Area
8.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By Target Area
8.5. Global Intelligent Pills Market Analysis, By Target Area
8.6. Global Intelligent Pills Market Attractiveness Analysis, By Target Area

9. Global Intelligent Pills Market Analysis and Forecast, By Type
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Intelligent Pills Market Value Share Analysis, By Type
9.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By Type
9.5. Global Intelligent Pills Market Analysis, By Type
9.6. Global Intelligent Pills Market Attractiveness Analysis, By Type

10. Global Intelligent Pills Market Analysis and Forecast, By End user
10.1. Introduction and Definition
10.2. Key Findings
10.3. Global Intelligent Pills Market Value Share Analysis, By End user
10.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By End user
10.5. Global Intelligent Pills Market Analysis, By End user
10.6. Global Intelligent Pills Market Attractiveness Analysis, By End user

11. Global Intelligent Pills Market Analysis, by Region
11.1. Global Intelligent Pills Market Value Share Analysis, by Region
11.2. Global Intelligent Pills Market Size (US$ Bn) Forecast, by Region
11.3. Global Intelligent Pills Market Attractiveness Analysis, by Region

12. North America Intelligent Pills Market Analysis
12.1. Key Findings
12.2. North America Intelligent Pills Market Overview
12.3. North America Intelligent Pills Market Value Share Analysis, By Application
12.4. North America Intelligent Pills Market Forecast, By Application
12.4.1. Capsule Endoscopy
12.4.2. Drug Delivery
12.4.3. Patient Monitoring
12.5. North America Intelligent Pills Market Value Share Analysis, By Target Area
12.6. North America Intelligent Pills Market Forecast, By Target Area
12.6.1. Esophagus
12.6.2. Stomach
12.6.3. Small Intestine
12.6.4. Large Intestine
12.7. North America Intelligent Pills Market Value Share Analysis, By Type
12.8. North America Intelligent Pills Market Forecast, By Type
12.8.1. Occult GI Bleeding
12.8.2. Chron’s disease
12.8.3. Small bowel tumors
12.8.4. Celiac disease
12.8.5. Inherited polyposis syndromes
12.8.6. Neurological disorder
12.8.7. Other disease indications
12.9. North America Intelligent Pills Market Value Share Analysis, By End user
12.10. North America Intelligent Pills Market Forecast, By End user
12.10.1. Hospital Pharmacy
12.10.2. Clinics
12.10.3. Research Institutes
12.10.4. Home Healthcare
12.11. North America Intelligent Pills Market Value Share Analysis, by Country
12.12. North America Intelligent Pills Market Forecast, by Country
12.12.1. U.S.
12.12.2. Canada
12.13. North America Intelligent Pills Market Analysis, by Country
12.14. U.S. Intelligent Pills Market Forecast, By Application
12.14.1. Capsule Endoscopy
12.14.2. Drug Delivery
12.14.3. Patient Monitoring
12.15. U.S. Intelligent Pills Market Forecast, By Target Area
12.15.1. Esophagus
12.15.2. Stomach
12.15.3. Small Intestine
12.15.4. Large Intestine
12.16. U.S. Intelligent Pills Market Forecast, By Type
12.16.1. Occult GI Bleeding
12.16.2. Chron’s disease
12.16.3. Small bowel tumors
12.16.4. Celiac disease
12.16.5. Inherited polyposis syndromes
12.16.6. Neurological disorder
12.16.7. Other disease indications
12.17. U.S. Intelligent Pills Market Forecast, By End user
12.17.1. Hospital Pharmacy
12.17.2. Clinics
12.17.3. Research Institutes
12.17.4. Home Healthc

12.18. Canada Intelligent Pills Market Forecast, By Application
12.18.1. Capsule Endoscopy
12.18.2. Drug Delivery
12.18.3. Patient Monitoring
12.19. Canada Intelligent Pills Market Forecast, By Target Area
12.19.1. Esophagus
12.19.2. Stomach
12.19.3. Small Intestine
12.19.4. Large Intestine
12.20. Canada Intelligent Pills Market Forecast, By Type
12.20.1. Occult GI Bleeding
12.20.2. Chron’s disease
12.20.3. Small bowel tumors
12.20.4. Celiac disease
12.20.5. Inherited polyposis syndromes
12.20.6. Neurological disorder
12.20.7. Other disease indications
12.21. Canada Intelligent Pills Market Forecast, By End user
12.21.1. Hospital Pharmacy
12.21.2. Clinics
12.21.3. Research Institutes
12.21.4. Home Healthcare
12.22. North America Intelligent Pills Market Attractiveness Analysis
12.22.1. By Application
12.22.2. By Target Area
12.22.3. By Type
12.22.4. By End user

12.23. PEST Analysis
12.24. Key Trends
12.25. Key Developments

13. Europe Intelligent Pills Market Analysis
13.1. Key Findings
13.2. Europe Intelligent Pills Market Overview
13.3. Europe Intelligent Pills Market Value Share Analysis, By Application
13.4. Europe Intelligent Pills Market Forecast, By Application
13.4.1. Capsule Endoscopy
13.4.2. Drug Delivery
13.4.3. Patient Monitoring
13.5. Europe Intelligent Pills Market Value Share Analysis, By Target Area
13.6. Europe Intelligent Pills Market Forecast, By Target Area
13.6.1. Esophagus
13.6.2. Stomach
13.6.3. Small Intestine
13.6.4. Large Intestine
13.7. Europe Intelligent Pills Market Value Share Analysis, By Type
13.8. Europe Intelligent Pills Market Forecast, By Type
13.8.1. Occult GI Bleeding
13.8.2. Chron’s disease
13.8.3. Small bowel tumors
13.8.4. Celiac disease
13.8.5. Inherited polyposis syndromes
13.8.6. Neurological disorder
13.8.7. Other disease indications
13.9. Europe Intelligent Pills Market Value Share Analysis, By End user
13.10. Europe Intelligent Pills Market Forecast, By End user
13.10.1. Hospital Pharmacy
13.10.2. Clinics
13.10.3. Research Institutes
13.10.4. Home Healthcare
13.11. Europe Intelligent Pills Market Value Share Analysis, by Country
13.12. Europe Intelligent Pills Market Forecast, by Country
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Europe Intelligent Pills Market Analysis, by Country
13.14. Germany Intelligent Pills Market Forecast, By Application
13.14.1. Capsule Endoscopy
13.14.2. Drug Delivery
13.14.3. Patient Monitoring
13.15. Germany Intelligent Pills Market Forecast, By Target Area
13.15.1. Esophagus
13.15.2. Stomach
13.15.3. Small Intestine
13.15.4. Large Intestine
13.16. Germany Intelligent Pills Market Forecast, By Type
13.16.1. Occult GI Bleeding
13.16.2. Chron’s disease
13.16.3. Small bowel tumors
13.16.4. Celiac disease
13.16.5. Inherited polyposis syndromes
13.16.6. Neurological disorder
13.16.7. Other disease indications
13.17. Germany Intelligent Pills Market Forecast, By End user
13.17.1. Hospital Pharmacy
13.17.2. Clinics
13.17.3. Research Institutes
13.17.4. Home Healthcare
13.18. U.K. Intelligent Pills Market Forecast, By Application
13.18.1. Capsule Endoscopy
13.18.2. Drug Delivery
13.18.3. Patient Monitoring
13.19. U.K. Intelligent Pills Market Forecast, By Target Area
13.19.1. Esophagus
13.19.2. Stomach
13.19.3. Small Intestine
13.19.4. Large Intestine
13.20. U.K. Intelligent Pills Market Forecast, By Type
13.20.1. Occult GI Bleeding
13.20.2. Chron’s disease
13.20.3. Small bowel tumors
13.20.4. Celiac disease
13.20.5. Inherited polyposis syndromes
13.20.6. Neurological disorder
13.20.7. Other disease indications
13.21. U.K. Intelligent Pills Market Forecast, By End user
13.21.1. Hospital Pharmacy
13.21.2. Clinics
13.21.3. Research Institutes
13.21.4. Home Healthcare
13.22. France Intelligent Pills Market Forecast, By Application
13.22.1. Capsule Endoscopy
13.22.2. Drug Delivery
13.22.3. Patient Monitoring
13.23. France Intelligent Pills Market Forecast, By Target Area
13.23.1. Esophagus
13.23.2. Stomach
13.23.3. Small Intestine
13.23.4. Large Intestine
13.24. France Intelligent Pills Market Forecast, By Type
13.24.1. Occult GI Bleeding
13.24.2. Chron’s disease
13.24.3. Small bowel tumors
13.24.4. Celiac disease
13.24.5. Inherited polyposis syndromes
13.24.6. Neurological disorder
13.24.7. Other disease indications
13.25. France Intelligent Pills Market Forecast, By End user
13.25.1. Hospital Pharmacy
13.25.2. Clinics
13.25.3. Research Institutes
13.25.4. Home Healthcare
13.26. Italy Intelligent Pills Market Forecast, By Application
13.26.1. Capsule Endoscopy
13.26.2. Drug Delivery
13.26.3. Patient Monitoring
13.27. Italy Intelligent Pills Market Forecast, By Target Area
13.27.1. Esophagus
13.27.2. Stomach
13.27.3. Small Intestine
13.27.4. Large Intestine
13.28. Italy Intelligent Pills Market Forecast, By Type
13.28.1. Occult GI Bleeding
13.28.2. Chron’s disease
13.28.3. Small bowel tumors
13.28.4. Celiac disease
13.28.5. Inherited polyposis syndromes
13.28.6. Neurological disorder
13.28.7. Other disease indications
13.29. Italy Intelligent Pills Market Forecast, By End user
13.29.1. Hospital Pharmacy
13.29.2. Clinics
13.29.3. Research Institutes
13.29.4. Home Healthcare
13.30. Spain Intelligent Pills Market Forecast, By Application
13.30.1. Capsule Endoscopy
13.30.2. Drug Delivery
13.30.3. Patient Monitoring
13.31. Spain Intelligent Pills Market Forecast, By Target Area
13.31.1. Esophagus
13.31.2. Stomach
13.31.3. Small Intestine
13.31.4. Large Intestine
13.32. Spain Intelligent Pills Market Forecast, By Type
13.32.1. Occult GI Bleeding
13.32.2. Chron’s disease
13.32.3. Small bowel tumors
13.32.4. Celiac disease
13.32.5. Inherited polyposis syndromes
13.32.6. Neurological disorder
13.32.7. Other disease indications
13.33. Spain Intelligent Pills Market Forecast, By End user
13.33.1. Hospital Pharmacy
13.33.2. Clinics
13.33.3. Research Institutes
13.33.4. Home Healthcare
13.34. Rest of Europe Intelligent Pills Market Forecast, By Application
13.34.1. Capsule Endoscopy
13.34.2. Drug Delivery
13.34.3. Patient Monitoring
13.35. Rest of Europe Intelligent Pills Market Forecast, By Target Area
13.35.1. Esophagus
13.35.2. Stomach
13.35.3. Small Intestine
13.35.4. Large Intestine
13.36. Rest of Europe Intelligent Pills Market Forecast, By Type
13.36.1. Occult GI Bleeding
13.36.2. Chron’s disease
13.36.3. Small bowel tumors
13.36.4. Celiac disease
13.36.5. Inherited polyposis syndromes
13.36.6. Neurological disorder
13.36.7. Other disease indications
13.37. Rest Of Europe Intelligent Pills Market Forecast, By End user
13.37.1. Hospital Pharmacy
13.37.2. Clinics
13.37.3. Research Institutes
13.37.4. Home Healthcare
13.38. Europe Intelligent Pills Market Attractiveness Analysis
13.38.1. By Application
13.38.2. By Target Area
13.38.3. By Type
13.38.4. By End user
13.39. PEST Analysis
13.40. Key Trends
13.41. Key Developments

14. Asia Pacific Intelligent Pills Market Analysis
14.1. Key Findings
14.2. Asia Pacific Intelligent Pills Market Overview
14.3. Asia Pacific Intelligent Pills Market Value Share Analysis, By Application
14.4. Asia Pacific Intelligent Pills Market Forecast, By Application
14.4.1. Capsule Endoscopy
14.4.2. Drug Delivery
14.4.3. Patient Monitoring
14.5. Asia Pacific Intelligent Pills Market Value Share Analysis, By Target Area
14.6. Asia Pacific Intelligent Pills Market Forecast, By Target Area
14.6.1. Esophagus
14.6.2. Stomach
14.6.3. Small Intestine
14.6.4. Large Intestine
14.7. Asia Pacific Intelligent Pills Market Value Share Analysis, By Type
14.8. Asia Pacific Intelligent Pills Market Forecast, By Type
14.8.1. Occult GI Bleeding
14.8.2. Chron’s disease
14.8.3. Small bowel tumors
14.8.4. Celiac disease
14.8.5. Inherited polyposis syndromes
14.8.6. Neurological disorder
14.8.7. Other disease indications
14.9. Asia Pacific Intelligent Pills Market Value Share Analysis, By End user
14.10. Asia Pacific Intelligent Pills Market Forecast, By End user
14.10.1. Hospital Pharmacy
14.10.2. Clinics
14.10.3. Research Institutes
14.10.4. Home Healthcare
14.11. Asia Pacific Intelligent Pills Market Value Share Analysis, by Country
14.12. Asia Pacific Intelligent Pills Market Forecast, by Country
14.12.1. China
14.12.2. India
14.12.3. Japan
14.12.4. ASEAN
14.12.5. Rest of Asia Pacific
14.13. Asia Pacific Intelligent Pills Market Analysis, by Country
14.14. China Intelligent Pills Market Forecast, By Application
14.14.1. Capsule Endoscopy
14.14.2. Drug Delivery
14.14.3. Patient Monitoring
14.15. China Intelligent Pills Market Forecast, By Target Area
14.15.1. Esophagus
14.15.2. Stomach
14.15.3. Small Intestine
14.15.4. Large Intestine
14.16. China Intelligent Pills Market Forecast, By Type
14.16.1. Occult GI Bleeding
14.16.2. Chron’s disease
14.16.3. Small bowel tumors
14.16.4. Celiac disease
14.16.5. Inherited polyposis syndromes
14.16.6. Neurological disorder
14.16.7. Other disease indications
14.17. China Intelligent Pills Market Forecast, By End user
14.17.1. Hospital Pharmacy
14.17.2. Clinics
14.17.3. Research Institutes
14.17.4. Home Healthcare
14.18. India Intelligent Pills Market Forecast, By Application
14.18.1. Capsule Endoscopy
14.18.2. Drug Delivery
14.18.3. Patient Monitoring
14.19. India Intelligent Pills Market Forecast, By Target Area
14.19.1. Esophagus
14.19.2. Stomach
14.19.3. Small Intestine
14.19.4. Large Intestine
14.20. India Intelligent Pills Market Forecast, By Type
14.20.1. Occult GI Bleeding
14.20.2. Chron’s disease
14.20.3. Small bowel tumors
14.20.4. Celiac disease
14.20.5. Inherited polyposis syndromes
14.20.6. Neurological disorder
14.20.7. Other disease indications
14.21. India Intelligent Pills Market Forecast, By End user
14.21.1. Hospital Pharmacy
14.21.2. Clinics
14.21.3. Research Institutes
14.21.4. Home Healthcare
14.22. Japan Intelligent Pills Market Forecast, By Application
14.22.1. Capsule Endoscopy
14.22.2. Drug Delivery
14.22.3. Patient Monitoring
14.23. Japan Intelligent Pills Market Forecast, By Target Area
14.23.1. Esophagus
14.23.2. Stomach
14.23.3. Small Intestine
14.23.4. Large Intestine
14.24. Japan Intelligent Pills Market Forecast, By Type
14.24.1. Occult GI Bleeding
14.24.2. Chron’s disease
14.24.3. Small bowel tumors
14.24.4. Celiac disease
14.24.5. Inherited polyposis syndromes
14.24.6. Neurological disorder
14.24.7. Other disease indications
14.25. Japan Intelligent Pills Market Forecast, By End user
14.25.1. Hospital Pharmacy
14.25.2. Clinics
14.25.3. Research Institutes
14.25.4. Home Healthcare
14.26. ASEAN Intelligent Pills Market Forecast, By Application
14.26.1. Capsule Endoscopy
14.26.2. Drug Delivery
14.26.3. Patient Monitoring
14.27. ASEAN Intelligent Pills Market Forecast, By Target Area
14.27.1. Esophagus
14.27.2. Stomach
14.27.3. Small Intestine
14.27.4. Large Intestine
14.28. ASEAN Intelligent Pills Market Forecast, By Type
14.28.1. Occult GI Bleeding
14.28.2. Chron’s disease
14.28.3. Small bowel tumors
14.28.4. Celiac disease
14.28.5. Inherited polyposis syndromes
14.28.6. Neurological disorder
14.28.7. Other disease indications
14.29. ASEAN Intelligent Pills Market Forecast, By End user
14.29.1. Hospital Pharmacy
14.29.2. Clinics
14.29.3. Research Institutes
14.29.4. Home Healthcare
14.30. Rest of Asia Pacific Intelligent Pills Market Forecast, By Application
14.30.1. Capsule Endoscopy
14.30.2. Drug Delivery
14.30.3. Patient Monitoring
14.31. Rest of Asia Pacific Intelligent Pills Market Forecast, By Target Area
14.31.1. Esophagus
14.31.2. Stomach
14.31.3. Small Intestine
14.31.4. Large Intestine
14.32. Rest of Asia Pacific Intelligent Pills Market Forecast, By Type
14.32.1. Occult GI Bleeding
14.32.2. Chron’s disease
14.32.3. Small bowel tumors
14.32.4. Celiac disease
14.32.5. Inherited polyposis syndromes
14.32.6. Neurological disorder
14.32.7. Other disease indications
14.33. Rest of Asia Pacific Intelligent Pills Market Forecast, By End user
14.33.1. Hospital Pharmacy
14.33.2. Clinics
14.33.3. Research Institutes
14.33.4. Home Healthcare
14.34. Asia Pacific Intelligent Pills Market Attractiveness Analysis
14.34.1. By Application
14.34.2. By Target Area
14.34.3. By Type
14.34.4. By End user
14.35. PEST Analysis
14.36. Key Trends
14.37. Key Developments

15. Middle East & Africa Intelligent Pills Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Intelligent Pills Market Overview
15.3. Middle East & Africa Intelligent Pills Market Value Share Analysis, By Application
15.4. Middle East & Africa Intelligent Pills Market Forecast, By Application
15.4.1. Capsule Endoscopy
15.4.2. Drug Delivery
15.4.3. Patient Monitoring
15.5. Middle East & Africa Intelligent Pills Market Value Share Analysis, By Target Area
15.6. Middle East & Africa Intelligent Pills Market Forecast, By Target Area
15.6.1. Esophagus
15.6.2. Stomach
15.6.3. Small Intestine
15.6.4. Large Intestine
15.7. Middle East & Africa Intelligent Pills Market Value Share Analysis, By Type
15.8. Middle East & Africa Intelligent Pills Market Forecast, By Type
15.8.1. Occult GI Bleeding
15.8.2. Chron’s disease
15.8.3. Small bowel tumors
15.8.4. Celiac disease
15.8.5. Inherited polyposis syndromes
15.8.6. Neurological disorder
15.8.7. Other disease indications
15.9. Middle East & Africa Intelligent Pills Market Value Share Analysis, By End user
15.10. Middle East & Africa Intelligent Pills Market Forecast, By End user
15.10.1. Hospital Pharmacy
15.10.2. Clinics
15.10.3. Research Institutes
15.10.4. Home Healthcare
15.11. Middle East & Africa Intelligent Pills Market Value Share Analysis, by Country
15.12. Middle East & Africa Intelligent Pills Market Forecast, by Country
15.12.1. GCC
15.12.2. South Africa
15.12.3. Rest of Middle East & Africa
15.13. Middle East & Africa Intelligent Pills Market Analysis, by Country
15.14. GCC Intelligent Pills Market Forecast, By Application
15.14.1. Capsule Endoscopy
15.14.2. Drug Delivery
15.14.3. Patient Monitoring
15.15. GCC Intelligent Pills Market Forecast, By Target Area
15.15.1. Esophagus
15.15.2. Stomach
15.15.3. Small Intestine
15.15.4. Large Intestine
15.16. GCC Intelligent Pills Market Forecast, By Type
15.16.1. Occult GI Bleeding
15.16.2. Chron’s disease
15.16.3. Small bowel tumors
15.16.4. Celiac disease
15.16.5. Inherited polyposis syndromes
15.16.6. Neurological disorder
15.16.7. Other disease indications
15.17. GCC Intelligent Pills Market Forecast, By End user
15.17.1. Hospital Pharmacy
15.17.2. Clinics
15.17.3. Research Institutes
15.17.4. Home Healthcare
15.18. South Africa Intelligent Pills Market Forecast, By Application
15.18.1. Capsule Endoscopy
15.18.2. Drug Delivery
15.18.3. Patient Monitoring
15.19. South Africa Intelligent Pills Market Forecast, By Target Area
15.19.1. Esophagus
15.19.2. Stomach
15.19.3. Small Intestine
15.19.4. Large Intestine
15.20. South Africa Intelligent Pills Market Forecast, By Type
15.20.1. Occult GI Bleeding
15.20.2. Chron’s disease
15.20.3. Small bowel tumors
15.20.4. Celiac disease
15.20.5. Inherited polyposis syndromes
15.20.6. Neurological disorder
15.20.7. Other disease indications
15.21. South Africa Intelligent Pills Market Forecast, By End user
15.21.1. Hospital Pharmacy
15.21.2. Clinics
15.21.3. Research Institutes
15.21.4. Home Healthcare
15.22. Rest of Middle East & Africa Intelligent Pills Market Forecast, By Application
15.22.1. Capsule Endoscopy
15.22.2. Drug Delivery
15.22.3. Patient Monitoring
15.23. Rest of Middle East & Africa Intelligent Pills Market Forecast, By Target Area
15.23.1. Esophagus
15.23.2. Stomach
15.23.3. Small Intestine
15.23.4. Large Intestine
15.24. Rest of Middle East & Africa Intelligent Pills Market Forecast, By Type
15.24.1. Occult GI Bleeding
15.24.2. Chron’s disease
15.24.3. Small bowel tumors
15.24.4. Celiac disease
15.24.5. Inherited polyposis syndromes
15.24.6. Neurological disorder
15.24.7. Other disease indications
15.25. Rest of Middle East & Africa Intelligent Pills Market Forecast, By End user
15.25.1. Hospital Pharmacy
15.25.2. Clinics
15.25.3. Research Institutes
15.25.4. Home Healthcare
15.26. Middle East & Africa Intelligent Pills Market Attractiveness Analysis
15.26.1. By Application
15.26.2. By Target Area
15.26.3. By Type
15.26.4. By End user
15.27. PEST Analysis
15.28. Key Trends
15.29. Key Developments

16. South America Intelligent Pills Market Analysis
16.1. Key Findings
16.2. South America Intelligent Pills Market Overview
16.3. South America Intelligent Pills Market Value Share Analysis, By Application
16.4. South America Intelligent Pills Market Forecast, By Application
16.4.1. Capsule Endoscopy
16.4.2. Drug Delivery
16.4.3. Patient Monitoring
16.5. South America Intelligent Pills Market Value Share Analysis, By Target Area
16.6. South America Intelligent Pills Market Forecast, By Target Area
16.6.1. Esophagus
16.6.2. Stomach
16.6.3. Small Intestine
16.6.4. Large Intestine
16.7. South America Intelligent Pills Market Value Share Analysis, By Type
16.8. South America Intelligent Pills Market Forecast, By Type
16.8.1. Occult GI Bleeding
16.8.2. Chron’s disease
16.8.3. Small bowel tumors
16.8.4. Celiac disease
16.8.5. Inherited polyposis syndromes
16.8.6. Neurological disorder
16.8.7. Other disease indications
16.9. South America Intelligent Pills Market Value Share Analysis, By End user
16.10. South America Intelligent Pills Market Forecast, By End user
16.10.1. Hospital Pharmacy
16.10.2. Clinics
16.10.3. Research Institutes
16.10.4. Home Healthcare
16.11. South America Intelligent Pills Market Value Share Analysis, by Country
16.12. South America Intelligent Pills Market Forecast, by Country
16.12.1. Brazil
16.12.2. Mexico
16.12.3. Rest of South America
16.13. South America Intelligent Pills Market Analysis, by Country
16.14. Brazil Intelligent Pills Market Forecast, By Application
16.14.1. Capsule Endoscopy
16.14.2. Drug Delivery
16.14.3. Patient Monitoring
16.15. Brazil Intelligent Pills Market Forecast, By Target Area
16.15.1. Esophagus
16.15.2. Stomach
16.15.3. Small Intestine
16.15.4. Large Intestine
16.16. Brazil Intelligent Pills Market Forecast, By Type
16.16.1. Occult GI Bleeding
16.16.2. Chron’s disease
16.16.3. Small bowel tumors
16.16.4. Celiac disease
16.16.5. Inherited polyposis syndromes
16.16.6. Neurological disorder
16.16.7. Other disease indications
16.17. Brazil Intelligent Pills Market Forecast, By End user
16.17.1. Hospital Pharmacy
16.17.2. Clinics
16.17.3. Research Institutes
16.17.4. Home Healthcare
16.18. Mexico Intelligent Pills Market Forecast, By Application
16.18.1. Capsule Endoscopy
16.18.2. Drug Delivery
16.18.3. Patient Monitoring
16.19. Mexico Intelligent Pills Market Forecast, By Target Area
16.19.1. Esophagus
16.19.2. Stomach
16.19.3. Small Intestine
16.19.4. Large Intestine
16.20. Mexico Intelligent Pills Market Forecast, By Type
16.20.1. Occult GI Bleeding
16.20.2. Chron’s disease
16.20.3. Small bowel tumors
16.20.4. Celiac disease
16.20.5. Inherited polyposis syndromes
16.20.6. Neurological disorder
16.20.7. Other disease indications
16.21. Mexico Intelligent Pills Market Forecast, By End user
16.21.1. Hospital Pharmacy
16.21.2. Clinics
16.21.3. Research Institutes
16.21.4. Home Healthcare
16.22. Rest of South America Intelligent Pills Market Forecast, By Application
16.22.1. Capsule Endoscopy
16.22.2. Drug Delivery
16.22.3. Patient Monitoring
16.23. Rest of South America Intelligent Pills Market Forecast, By Target Area
16.23.1. Esophagus
16.23.2. Stomach
16.23.3. Small Intestine
16.23.4. Large Intestine
16.24. Rest of South America Intelligent Pills Market Forecast, By Type
16.24.1. Occult GI Bleeding
16.24.2. Chron’s disease
16.24.3. Small bowel tumors
16.24.4. Celiac disease
16.24.5. Inherited polyposis syndromes
16.24.6. Neurological disorder
16.24.7. Other disease indications
16.25. Rest of South America Intelligent Pills Market Forecast, By End user
16.25.1. Hospital Pharmacy
16.25.2. Clinics
16.25.3. Research Institutes
16.25.4. Home Healthcare
16.26. South America Intelligent Pills Market Attractiveness Analysis
16.26.1. By Application
16.26.2. By Target Area
16.26.3. By Type
16.26.4. By End user
16.27. PEST Analysis
16.28. Key Trends
16.29. Key Developments

17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
17.2.2. New Product Launches and Product Enhancements
17.2.3. Market Consolidation
17.2.3.1. M&A by Regions, Investment and Applications
17.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
17.1. Company Profiles: Key Players
17.1.1. Bayer
17.1.1.1. Company Overview
17.1.1.2. Financial Overview
17.1.1.3. Product Portfolio
17.1.1.4. Business Strategy
17.1.1.5. Recent Developments
17.1.1.6. Development Footprint
17.1.2. Biogen
17.1.3. Merck KGaA
17.1.4. Teva
17.1.5. Sanofi
17.1.6. Novartis
17.1.7. Roche
17.1.8. Acorda Therapeutics, Inc.
17.1.9. EMD Serono (Merck KGaA)
17.1.10. AbbVie, Inc
17.1.11. Actelion
17.1.12. Celgene
17.1.13. AbbVie
17.1.14. Alkermes
17.1.15. TG Therapeutics
17.1.16. GeNeuro
17.1.17. Antisense Therapeutics
17.1.18. AB Science
17.1.19. MedDay
17.1.20. Coherus Bioscience
17.1.21. InnoBioscience
17.1.22. MediciNova
17.1.23. Santhera Pharmaceuticals
17.1.24. GSK
17.1.25. Ionis Pharmaceutical

18. Primary Key Insights
  • INQUIRE BEFORE BUYING